Key Performance
More- Earnings Score: 75
- Momentum Score: 46
- True Yield: N/A
- Financial Health Score: 59
%20scale(1,1)}%2025%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(1,1)}}%20%23ewMkZ6d8Hun3_ts%20{animation:%20ewMkZ6d8Hun3_ts__ts%204000ms%20linear%20infinite%20normal%20forwards}@keyframes%20ewMkZ6d8Hun3_ts__ts%20{%200%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}%2025%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}}%20]]%3e%3c/style%3e%3cdefs%3e%3clinearGradient%20id='ewMkZ6d8Hun2-fill'%20x1='12.5'%20y1='23.5001'%20x2='-0.868518'%20y2='16.4047'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun2-fill-0'%20offset='0%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun2-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3clinearGradient%20id='ewMkZ6d8Hun3-fill'%20x1='31.5059'%20y1='27.1026'%20x2='10.2884'%20y2='14.9373'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun3-fill-0'%20offset='4.7%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun3-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3c/defs%3e%3cg%20id='ewMkZ6d8Hun2_ts'%20transform='translate(24.943161,19.954806)%20scale(1,1)'%3e%3cpath%20d='M14.8466,29.2814c0,0-14.408088-4.6983-12.05895-19.79995c0,0,1.50345,4.85085,4.13448,5.30845s-2.03592,4.6373,7.92447,14.4915Z'%20transform='translate(-24.943161,-19.954806)'%20fill='url(%23ewMkZ6d8Hun2-fill)'/%3e%3c/g%3e%3cg%20id='ewMkZ6d8Hun3_ts'%20transform='translate(24.9787,20.012362)%20scale(1,1)'%3e%3cpath%20d='M37.4922,21.9282l4.0719.244v-12.81353C31.0713,3.28748,17.7595,7.6502,17.7595,7.6502c.3445-4.51526-3.5707-5.52204-3.5707-5.52204c2.5371,1.52542.3132,6.22373.3132,6.22373C13.0299,0.084092,0,1.02986,0,1.02986C8.92672,4.35528,6.70287,7.98579,6.8908,16.6197c.18794,8.6034,8.3943,12.9966,8.3943,12.9966l-6.60895-.2441v13.2407c0,0,5.48135,2.3797,13.68765,3.1729v-22.3017h-4.4477c-1.0023,0-1.942-.8237-1.942-1.8v-5.7356c0-.9763.9397-1.8,1.942-1.8h4.4477v-1.3424h5.0115v1.3424h5.0115c1.0023,0,1.848.7932,1.848,1.8v5.7356c0,.9763-.8144,1.8-1.848,1.8h-5.0115v22.5153h.2819c11.1192-.0611,15.9428-7.3221,16.256-13.3017.4698-7.7492-6.421-10.7695-6.421-10.7695Z'%20transform='translate(-24.9787,-20.012361)'%20fill='url(%23ewMkZ6d8Hun3-fill)'/%3e%3c/g%3e%3c/svg%3e)
Latest Research & News
Law firm Bragar Eagel & Squire is investigating Alphatec Holdings for potential federal securities law violations following the company's May 5, 2026 earnings miss. Alphatec reported lower-than-expected Q1 2026 revenue, reduced full-year EOS revenue guidance, and disclosed unfulfilled unit commitments due to installation timing challenges. The stock price declined following the announcement.
06/03/2026, 5:35 PM • GlobeNewswire
The Schall Law Firm is investigating Alphatec Holdings for potential securities fraud following the company's May 5, 2026 Q1 earnings report, which revealed missed revenue estimates, lower deliveries than prior year, and reduced full-year 2026 guidance. The stock fell 31.7% on May 6, 2026, after the company admitted to failing to fulfill committed unit deliveries.
05/24/2026, 12:05 PM • GlobeNewswire
The Law Offices of Frank R. Cruz is investigating Alphatec Holdings for potential federal securities law violations. On May 5, 2026, Alphatec reported Q1 2026 results that missed revenue consensus estimates, with lower deliveries and reduced full-year EOS revenue outlook. The company cited installation timing challenges and unfulfilled unit commitments. The stock fell 31.7% to $6.99 on May 6, 2026.
05/22/2026, 12:51 PM • Benzinga
Law firm Kirby McInerney LLP is investigating potential securities law violations by Alphatec Holdings following the company's May 5, 2026 earnings report. Alphatec disclosed Q1 2026 revenue of $192 million with EOS platform revenue of $14 million, missing internal expectations due to installation delays and unfulfilled unit commitments. The company reduced its full-year EOS revenue guidance from $85 million to $77 million. The stock declined 32% from $10.23 to $6.99 following the announcement.
05/21/2026, 7:00 PM • GlobeNewswire
A securities fraud investigation has been announced against Alphatec Holdings, Inc. following the company's May 5, 2026 earnings miss. Alphatec reported lower-than-expected revenue, reduced full-year EOS revenue outlook, and disclosed installation timing challenges and unfulfilled unit commitments. The stock fell 31.7% to $6.99 per share on May 6, 2026.
05/15/2026, 12:00 PM • Benzinga
The Law Offices of Frank R. Cruz announced a securities fraud investigation into Alphatec Holdings, Inc. following the company's May 5, 2026 earnings miss. Alphatec reported lower-than-expected revenue, reduced full-year 2026 guidance, and disclosed challenges with EOS installation timing and unfulfilled unit commitments. The stock fell 31.7% to $6.99 per share on May 6, 2026.
05/14/2026, 4:16 PM • Benzinga
Alphatec Stock Up 126% as CEO Sells $2 Million in Shares -- Here's What Investors Should Know
Alphatec Holdings CEO Miles Patrick sold 100,000 shares worth $2.1 million in a prearranged transaction, reducing his direct holdings by 6.82%. Despite the insider sale, the article maintains a bullish outlook, noting the company's strong operational momentum with 30% YoY revenue growth, expanding margins, and raised full-year guidance. The CEO retains over 5.1 million shares, maintaining alignment with shareholders.
01/11/2026, 1:27 PM • The Motley Fool
Is Alphatec Stock a Buy or Sell After Its COO Dumped Nearly 20,000 Shares?
Alphatec Holdings COO Scott Lish sold 19,900 shares worth approximately $390,836 on December 16, 2025. Despite the insider sale, the article suggests this is not a red flag as Lish retained over 640,000 shares. The sale occurred during a strong price run-up (127% annual return), with the stock's P/S ratio doubling to over 4x. While the company shows solid fundamentals with 30% YoY revenue growth and improving margins, the analyst recommends waiting for a price pullback before buying.
12/26/2025, 8:07 PM • The Motley Fool
Alphatec Executive Unloads 100,000 Shares for $2 Million on Earnings Beat
Alphatec Holdings' HR executive Craig Hunsaker sold 100,000 shares worth $2 million, representing 7.2% of his stake. The company has seen strong quarterly performance with 30% revenue growth and is approaching positive free cash flow in 2025.
12/09/2025, 9:29 AM • The Motley Fool
Peers
Statistics
MoreInformation as of 06/22/2026
Company Profile
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissue; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. The company was founded in 1990 and is headquartered in Carlsbad, California.